Cell Free RNA Isolation & Extraction Kits Market to Grow with a CAGR of 18.19% through 2030
Growing prevalence of cancer
and rise in cases with prenatal complications to drive the cell free RNA
isolation & extraction kits market in the forecast period, 2026-2030.
According to TechSci Research report, “Cell
Free RNA Isolation & Extraction Kits Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2030”, the Global Cell Free RNA Isolation & Extraction Kits Market was valued at USD 53.27 million in 2024 and is expected to reach USD 145.23 million by 2030 with a CAGR of 18.19% during the forecast period. The increase in incidences of different types of cancer, and
growing number of cases with prenatal complications are the primary factors
driving the demand for the global cell free RNA isolation & extraction kits
market. Growing technological advancements, rise in geriatric population, awareness
among patient population about non-invasive techniques, and heavy investments
in healthcare sector are expected to influence the market demand. Also, strategic
partnerships and collaborations by biotechnology and pharmaceutical companies are
also a key factor for increasing the growth of the cell free RNA isolation
& extraction kits market, globally.
However, the lack of skilled professionals and
awareness related to cell-free RNA methods and ethical, legal, and social
issues related with prenatal screening can hamper the growth of the global cell
free RNA isolation & extraction kits market.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Global Cell Free RNA Isolation & Extraction Kits Market"
The global cell free RNA
isolation & extraction kits market is segmented into application, end user, regional distribution and company.
Based on End User, pharmaceutical and biotechnology companies represent the fastest-growing end-user segment. This growth is primarily driven by the surge in drug discovery, precision medicine research, and the development of non-invasive diagnostic tools that rely heavily on cfRNA-based technologies. Pharmaceutical and biotech firms are increasingly integrating cfRNA analysis into clinical trials to identify biomarkers for treatment response and disease progression. According to the U.S. National Institutes of Health (NIH) ClinicalTrials.gov, there are over 450,000 registered clinical studies globally (as of 2024), with a significant portion involving oncology, neurology, and metabolic disorders—all of which utilize cfRNA for biomarker research. The growing reliance on cfRNA data in these trials accelerates the need for advanced isolation and extraction kits. Governments are also fueling this demand through strong funding support for genomics and molecular diagnostics research. For example, the European Union’s Horizon Europe program allocated nearly €7 billion for health research from 2021–2027, with a focus on personalized medicine and biomarker discovery. In parallel, the U.S. FDA has been encouraging the adoption of novel biomarkers for regulatory submissions, further incentivizing pharmaceutical and biotech firms to adopt cfRNA technologies.
Based on Region, The Asia Pacific region is witnessing the fastest growth in the Global Cell-Free RNA Isolation & Extraction Kits Market, driven by expanding healthcare infrastructure, rising investments in genomics, and a growing emphasis on precision medicine. Countries such as China, Japan, South Korea, and India are at the forefront of this expansion, supported by both government initiatives and private sector investments. China has significantly scaled up its genomics and molecular biology research through projects such as the China Precision Medicine Initiative, which aims to invest billions of dollars into personalized healthcare by 2030. Similarly, Japan’s government-backed Moonshot Research and Development Program supports innovations in early disease detection and non-invasive diagnostics, encouraging the adoption of cfRNA technologies. India is also emerging as a key player, with government programs under the Department of Biotechnology (DBT) supporting translational research in cancer and infectious diseases, both of which rely heavily on RNA-based diagnostics.
Major operating companies
operating in Global Cell Free RNA Isolation & extraction kits market are:
- F.Hoffmann-La Roche AG
- JBS Science Inc.
- Aline Biosciences
- Apostle Inc. (Apostle Sciences)
- Danagen-Bioted, S.L.
- Norgen Biotek Corp.
- PerkinElmer, Inc.
- Promega Corporation
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“North America region dominates the
market and is expected to maintain its dominance in the coming years
due to increase in patient numbers suffering from prenatal complications,
metabolic disorders, and various kinds of cancer. The strongly established
research and healthcare infrastructure, emerging new technologies, rising
awareness among population, and heavy investments by government in the region
is another key factor. Also, owing to strategic acquisitions and partnerships by biotechnology and
pharmaceutical companies in
the region are expected to propel the global cell free RNA isolation &
extraction kits market growth” said Mr. Karan Chechi, Research
Director of TechSci Research, a research based global management consulting
firm.
“Cell Free RNA Isolation
& Extraction Kits Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Application (Oncology,
Prenatal Screening, Metabolic Disorders, Others), By End User (Hospitals &
Clinics, Pharmaceutical & Biotechnology Companies, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global cell
free RNA isolation & extraction kits market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global cell free RNA isolation & extraction kits market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com